PMID: 6971121Feb 3, 1981Paper

Active center studies on bacterial luciferase: modification of the enzyme with 2,4-dinitrofluorobenzene

Biochemistry
W R Welches, T O Baldwin

Abstract

Bacterial luciferase catalyzes the mixed-function oxidation of a long-chain saturated aldehyde and FMNH2 to yield the carboxylic acid, FMN, and blue-green light. The enzyme was inactivated by 2,4-dinitrofluorobenzene (FDNB) with an observed second-order rate constant (k2(obsd) of 157 M-1 min-1 at pH 7.0, 25 degrees C; activity was not recovered upon treatment with 2-mercaptoethanol (thiolysis), demonstrating that the inactivation was the result of reaction with one or more amino groups. The dinitrophenyl (DNP) moiety was incorporated into the alpha subunit approximately twice as fast as it was incorporated into the beta subunit; the rate of inactivation was nearly identical with the rate of incorporation into the alpha beta dimer. The incorporation of 1 mol of DNP/alpha beta resulted in complete inactivation, demonstrating that modification of either alpha or beta is sufficient to cause inactivation. Incorporation of DNP into one subunit appeared to either block or decrease the rate of incorporation of DNP into the other subunit. The luciferase was protected from inactivation by binding of long-chain aldehydes or FMN. Following modification by FDNB, the enzyme had lost measurable FMNH2 binding. The apparent pKa of the amino gro...Continue Reading

References

Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·T O BaldwinD A Powers
Aug 15, 1975·European Journal of Biochemistry·R A Laskey, A D Mills
Aug 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·O ShimomuraY Kohama
May 1, 1973·Biochemical and Biophysical Research Communications·F McCapra, D W Hysert
Apr 23, 1974·Biochemical and Biophysical Research Communications·T O Baldwin
Jul 1, 1974·European Journal of Biochemistry·W M Bonner, R A Laskey
Dec 1, 1967·Proceedings of the National Academy of Sciences of the United States of America·J Friedland, J W Hastings
Dec 1, 1969·Biochemistry·J W HastingsA Gunsalus
Oct 1, 1969·The Biochemical Journal·P J Quinn, R M Dawson
Jan 1, 1971·Analytical Biochemistry·G W Mitchell, J W Hastings
Oct 26, 1967·Biochemical and Biophysical Research Communications·S Shaltiel
Jan 29, 1980·Biochemical and Biophysical Research Communications·E M Kosower
Jan 1, 1945·The Biochemical Journal·F Sanger
Jan 1, 1948·The Biochemical Journal·R R Porter, F Sanger

❮ Previous
Next ❯

Citations

May 8, 1990·Biochimica Et Biophysica Acta·C M LinR J Krueger
Dec 19, 2001·Archives of Biochemistry and Biophysics·C J WeiS C Tu
Aug 1, 1988·Archives of Biochemistry and Biophysics·O PaquatteS C Tu
May 1, 1982·Archives of Biochemistry and Biophysics·H WatanabeS C Tu
Jul 1, 1989·Journal of Bioluminescence and Chemiluminescence·T O BaldwinM M Ziegler
Oct 26, 2006·Journal of Agricultural and Food Chemistry·Lih-Shiuh LaiCheng-Hsin Wang
Aug 14, 2008·Journal of Agricultural and Food Chemistry·Lih-Shiuh LaiChen-Tien Chang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.